Position in NVS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$19,276
+$488 QoQ
Shares Held
123
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,494
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Princeton Global Asset Management LLC holds $25,670,962 across 14 Drug Manufacturers - General names. NVS ranks #12 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
41,882 | $10,636,771 | |
| 2 | LLY |
ELI LILLY & Co
|
5,815 | $6,974,686 | |
| 3 | ABBV |
AbbVie Inc.
|
26,493 | $6,666,698 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,825 | $491,512 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,594 | $201,385 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,450 | $198,789 | |
| 7 | AMGN |
Amgen Inc
|
499 | $180,697 | |
| 8 | AZN |
Astrazeneca PLC
|
828 | $157,005 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,276 | 123 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $18,788 | 123 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $16,958 | 123 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $15,773 | 123 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $14,884 | 123 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $4,236 | 38 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $3,697 | 38 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $4,370 | 38 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $4,045 | 38 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,675 | 38 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $13,933 | 138 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $14,056 | 138 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $13,925 | 138 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $12,696 | 138 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $9,072 | 100 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $7,601 | 100 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,453 | 100 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $8,775 | 100 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $840,149 | 9,605 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $808,804 | 9,890 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $977,180 | 10,710 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $955,837 | 11,182 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,057,616 | 11,200 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,008,649 | 11,599 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,159,351 | 13,274 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,108,045 | 13,439 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||